Research Facility

Jacksonville, Florida 32256

1 studies enrolling now · 8 studies all time

What they study most

Advanced Breast Cancer, Arrhythmias, Carcinoid, Carcinoid Tumor, ER+ Breast Cancer, GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease, HER2-negative Breast Cancer, Hepatocellular Carcinoma (HCC), Metastatic Breast Cancer, Neuroendocrine Tumors

Studies at this site

• Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC — Recruiting now
• Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy — Recruiting now
• Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC — Running, not enrolling
• Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs. — Running, not enrolling
• Long Term Safety of 125 mg Per Day of Oral Azimilide in Patients With Implantable Cardioverter Defibrillator (ICDs) — Completed
• A Comparison of Once a Day Dose Compared to 2 Doses/Day — Completed
• A Double Blind Study for the Treatment of Acute Ulcerative Colitis — Completed
• A Dose-Ranging Study of ATI 7505 in Patients With Postprandial Distress Syndrome — Stopped early